Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S12 pseudogene 25 (RPS12P25) is a processed pseudogene in the human genome related to the functional ribosomal protein S12 gene[1][9][11]. Unlike the parent ribosomal protein S12 gene, which encodes an essential component of the ribosome involved in protein synthesis and fidelity of mRNA decoding[4][7][13], RPS12P25 does not produce a functional protein. Pseudogenes are considered defunct copies, typically the result of gene duplication or retrotransposition followed by loss of coding potential[6]. While most pseudogenes are transcriptionally inactive, some—in rare cases—can be transcribed and may influence the regulation of their parent genes, but there is no evidence supporting a functional role or therapeutic relevance for RPS12P25 in humans[6][1][11]. In summary, RPS12P25 is a non-functional pseudogene and not a genuine molecular target. Any references to therapeutic targeting, disease roles, interacting drugs, or biomarker utility are not applicable to this entity. If you intended a functional ribosomal protein target, refer instead to the parent gene RPS12 (ribosomal protein S12)[4][7][13].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S12 pseudogene 25 (RPS12P25).